首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   41277篇
  免费   2592篇
  国内免费   654篇
耳鼻咽喉   106篇
儿科学   1885篇
妇产科学   2612篇
基础医学   3287篇
口腔科学   290篇
临床医学   3810篇
内科学   9555篇
皮肤病学   539篇
神经病学   2485篇
特种医学   780篇
外科学   3788篇
综合类   3476篇
现状与发展   1篇
一般理论   8篇
预防医学   6136篇
眼科学   1057篇
药学   1798篇
  1篇
中国医学   319篇
肿瘤学   2590篇
  2023年   292篇
  2022年   197篇
  2021年   397篇
  2020年   399篇
  2019年   158篇
  2018年   575篇
  2017年   576篇
  2016年   655篇
  2015年   642篇
  2014年   635篇
  2013年   942篇
  2012年   2433篇
  2011年   3530篇
  2010年   1384篇
  2009年   1079篇
  2008年   2966篇
  2007年   2798篇
  2006年   2500篇
  2005年   2664篇
  2004年   3399篇
  2003年   3486篇
  2002年   2626篇
  2001年   2125篇
  2000年   715篇
  1999年   713篇
  1998年   677篇
  1997年   634篇
  1996年   453篇
  1995年   400篇
  1994年   536篇
  1993年   464篇
  1992年   481篇
  1991年   452篇
  1990年   357篇
  1989年   321篇
  1988年   245篇
  1987年   249篇
  1986年   205篇
  1985年   152篇
  1984年   100篇
  1983年   86篇
  1982年   82篇
  1981年   81篇
  1980年   65篇
  1979年   65篇
  1978年   45篇
  1977年   47篇
  1976年   39篇
  1975年   51篇
  1973年   55篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
结核病与糖尿病均是临床上的常见病和多发病,两者可合并存在,相互影响。活动性结核病作为感染因素可加重糖尿病病情,而糖尿病患者又是发生结核病的高危人群,结核病与糖尿病双重负担将成为重大的全球公共卫生问题。因此,需重视结核病与糖尿病共病的治疗管理。本共识重点介绍了结核病与糖尿病共病的危害、发病机制、双向筛查、临床特点、诊断、治疗和管理等内容。  相似文献   
6.
【摘要】 皮肤鳞状细胞癌是非黑素瘤皮肤癌中最常见的肿瘤之一。近年来随着对其发病机制研究的深入以及诊断技术、Mohs显微描记手术、靶向治疗、免疫治疗的发展,皮肤鳞状细胞癌的诊疗取得了较大进展。该共识在国内外近期文献及诊疗指南的基础上,结合我国的诊疗现状,重点阐述皮肤鳞状细胞癌的临床表现及分型、病理活检及报告规范、风险等级评估、分级分期以及规范化治疗等,为临床医生的诊疗工作提供参考依据。  相似文献   
7.
【摘要】 介入手术后医院感染严重危害人类健康。制定介入手术室医院感染控制和预防临床实践专家共识可更好地规范介入手术过程中相关临床实践标准,降低医院感染发生率。本共识基于 WHO指南制定手册和GRADE证据质量分级系统,形成了介入手术室环境管理、患者管理、工作人员管理、物品管理、职业暴露、培训与质量控制等6个领域54项推荐意见,供相关人员参考。  相似文献   
8.
Since the start of the COVID-19 pandemic, few studies have reported anaesthetic outcomes in parturients with SARS-CoV-2 infection. We reviewed the labour analgesic and anaesthetic interventions utilised in symptomatic and asymptomatic parturients who had a confirmed positive test for SARS-CoV-2 across 10 hospitals in the north-west of England between 1 April 2020 and 31 May 2021. Primary outcomes analysed included the analgesic/anaesthetic technique utilised for labour and caesarean birth. Secondary outcomes included a comparison of maternal characteristics, caesarean birth rate, maternal critical care admission rate along with adverse composite neonatal outcomes. A positive SARS-CoV-2 test was recorded in 836 parturients with 263 (31.4%) reported to have symptoms of COVID-19. Neuraxial labour analgesia was utilised in 104 (20.4%) of the 509 parturients who went on to have a vaginal birth. No differences in epidural analgesia rates were observed between symptomatic and asymptomatic parturients (OR 1.03, 95%CI 0.64–1.67; p = 0.90). The neuraxial anaesthesia rate in 310 parturients who underwent caesarean delivery was 94.2% (95%CI 90.6–96.0%). The rates of general anaesthesia were similar in symptomatic and asymptomatic parturients (6% vs. 5.7%; p = 0.52). Symptomatic parturients were more likely to be multiparous (OR 1.64, 95%CI 1.19–2.22; p = 0.002); of Asian ethnicity (OR 1.54, 1.04–2.28; p = 0.03); to deliver prematurely (OR 2.16, 95%CI 1.47–3.19; p = 0.001); have a higher caesarean birth rate (44.5% vs. 33.7%; OR 1.57, 95%CI 1.16–2.12; p = 0.008); and a higher critical care utilisation rate both pre- (8% vs. 0%, p = 0.001) and post-delivery (11% vs. 3.5%; OR 3.43, 95%CI 1.83–6.52; p = 0.001). Eight neonates tested positive for SARS-CoV-2 while no differences in adverse composite neonatal outcomes were observed between those born to symptomatic and asymptomatic mothers (25.8% vs. 23.8%; OR 1.11, 95%CI 0.78–1.57; p = 0.55). In women with COVID-19, non-neuraxial analgesic regimens were commonly utilised for labour while neuraxial anaesthesia was employed for the majority of caesarean births. Symptomatic women with COVID-19 are at increased risk of significant maternal morbidity including preterm birth, caesarean birth and peripartum critical care admission.  相似文献   
9.
The Earth’s mean surface temperature is already approximately 1.1°C higher than pre-industrial levels. Exceeding a mean 1.5°C rise by 2050 will make global adaptation to the consequences of climate change less possible. To protect public health, anaesthesia providers need to reduce the contribution their practice makes to global warming. We convened a Working Group of 45 anaesthesia providers with a recognised interest in sustainability, and used a three-stage modified Delphi consensus process to agree on principles of environmentally sustainable anaesthesia that are achievable worldwide. The Working Group agreed on the following three important underlying statements: patient safety should not be compromised by sustainable anaesthetic practices; high-, middle- and low-income countries should support each other appropriately in delivering sustainable healthcare (including anaesthesia); and healthcare systems should be mandated to reduce their contribution to global warming. We set out seven fundamental principles to guide anaesthesia providers in the move to environmentally sustainable practice, including: choice of medications and equipment; minimising waste and overuse of resources; and addressing environmental sustainability in anaesthetists’ education, research, quality improvement and local healthcare leadership activities. These changes are achievable with minimal material resource and financial investment, and should undergo re-evaluation and updates as better evidence is published. This paper discusses each principle individually, and directs readers towards further important references.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号